JACC: Case Reports (Feb 2023)

1,1-Difluoroethane Hydrocarbon Cardiomyopathy

  • Kristen N. Brown, MD,
  • Kyle Gronbeck, MD,
  • Ayesha Azmeen, MBBS,
  • Aleem Siddique, MBBS,
  • Ronald Zolty, MD, PhD,
  • James N. Sullivan, MD

Journal volume & issue
Vol. 7
p. 101716

Abstract

Read online

1,1-Difluoroethane (DFE) cardiomyopathy results from the direct inhalation of toxic halogenated hydrocarbons. We present a case series of acute DFE cardiomyopathy illustrating the typical presentation of severe DFE cardiomyopathy along with a detailed description of its mechanism of injury. (Level of Difficulty: Advanced.)

Keywords